News
Among patients with severe asthma receiving dupilumab for 12 months, 91% had a clinical response and 30% achieved clinical remission.
While you may start with a certain regimen, you may not sick to it. Here are 7 signs that your asthma medication isn't ...
Asthma is a condition with varying levels of care for a variety of reasons; it is critical that people with asthma symptoms ...
The latest UK asthma guidelines1 clearly define the role of Fractional exhaled Nitric Oxide (FeNO) testing in both diagnosing ...
While your morning brew might feel harmless, it can interact with certain medicines to reduce effectiveness or increase side ...
UK MHRA approves ALK’s EURneffy, a needle-free anaphylaxis treatment of adults and children in UK: Hørsholm, Denmark Monday, July 21, 2025, 14:00 Hrs [IST] ALK, a global specia ...
Dr. Arjumand Faisel MBBS, MCPS, MPH, FCPS is a leading Public Health Specialist in Pakistan. He graduated in 1979 from Dow ...
A new scientific discovery is offering a promising breakthrough for people struggling with hay fever and asthma triggered by ...
Chronic Rhinosinusitis With Nasal Polyps and Asthma: Understanding the Connection and Treatment Gaps
Chronic rhinosinusitis with nasal polyps increases the likelihood of developing coexisting conditions, such as asthma, underscoring the need for more effective, comprehensive treatments.
Use of a pMDI with a holding chamber is noninferior to nebulization for delivering salbutamol in children with asthma exacerbations.
Risk aversion to steroid side effects shaped treatment choices, underscoring support for tailored approaches in managing ...
Stepping down to as-needed ICS/FABA maintained asthma stability while significantly reducing steroid exposure in individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results